New Synthetic Strategies Toward DFO*: Enhanced Yield and Purity of a Key Chelator for

Nils F Baier, Minqian Miao, Ralf Schirrmacher, Björn Wängler, Gert Fricker, Carmen Wängler

Abstract read

In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nils F BaierBiomedical Chemistry, Clinic of Radiology and Nuclear Medicine, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.ORCID 0009-0000-7058-5938

Minqian MiaoBiomedical Chemistry, Clinic of Radiology and Nuclear Medicine, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.ORCID 0000-0001-5493-8895

Ralf SchirrmacherDivision of Oncological Imaging, Department of Oncology, University of Alberta, Edmonton, AB T6G 1Z2, Canada.ORCID 0000-0002-7098-3036

Björn WänglerMolecular Imaging and Radiochemistry, Clinic of Radiology and Nuclear Medicine, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.ORCID 0000-0003-3877-5576

Gert FrickerInstitute of Pharmacy and Molecular Biotechnology, Heidelberg University, 69120 Heidelberg, Germany.ORCID 0000-0003-3894-961X

Carmen WänglerBiomedical Chemistry, Clinic of Radiology and Nuclear Medicine, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.ORCID 0000-0003-1161-8669

Funding

Bundesministerium für Forschung, Technologie und Raumfahrt 13GW0747A

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

89Zracid labilityDFODFO*hydroxamate chelators

Identifiers

PMID42356432

DOI10.3390/ph19060813

PMCPMC13304809

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.